Search

everythinglearnresearchcommunity

for

Search:↓

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Finasteride may cause breast enlargement, low testosterone a risk factor.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Suppressing certain hormones might help prevent prostate cancer.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Dutasteride may help shrink prostate cancer tumors.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.